Product image of Zevalin (Ibritumomab Tiuxetan) supplied by GNH India

Zevalin

Active Ingredient:
Ibritumomab Tiuxetan
Origin:
EU

Zevalin (Ibritumomab Tiuxetan)

Zevalin (ibritumomab tiuxetan) is an intravenous therapy for certain types of cancer affecting the lymphatic system. It targets CD20-positive B-cells to support treatment of relapsed or refractory non-Hodgkin lymphoma. This radioimmunotherapy is administered under medical supervision. Short version: Zevalin treats specific lymphomas via targeted radioimmunotherapy in clinical settings.

Manufacturer / TM Owner

Ceft Biopharma S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zevalin is used in patients with relapsed or refractory non-Hodgkin lymphoma, particularly follicular B-cell types. It may be prescribed when other treatments have not been effective. The therapy targets CD20-positive B-cells to help manage cancer progression. Patients often ask, what is ibritumomab tiuxetan used for, and it is indicated for certain lymphomas after prior therapies.

Side Effects

  • After administration, Zevalin works by binding to B-cells and delivering targeted radiation. Patients may experience effects related to the underlying condition and treatment process. Common effects can include fatigue or temporary changes in blood cell counts. The therapy is designed to focus radiation on cancerous cells while sparing healthy tissue.

Precautions & Warnings

  • Zevalin requires careful handling and administration by healthcare professionals. Patients should inform their provider about all medications and medical conditions before treatment. Pregnant or breastfeeding individuals should avoid this therapy due to potential risks. Regular monitoring of blood counts and organ function is typically required during and after treatment.

Avoid Interactions

  • Zevalin may interact with other therapies affecting the immune system or blood cell production. Patients on immunosuppressive drugs or with recent live vaccines should discuss risks with their doctor. Alcohol and certain supplements may also interact; consult a healthcare provider. Always disclose all current medications to avoid potential complications.

Frequently Asked Questions

Zevalin is used to treat certain types of non-Hodgkin lymphoma, particularly in patients who have relapsed or not responded to other treatments.

Zevalin is given as an intravenous infusion under medical supervision, typically in a clinical setting.

Common effects may include fatigue or changes in blood cell counts; patients should discuss concerns with their healthcare provider.

Other medications may interact; always inform your doctor about all drugs and supplements you are taking before starting Zevalin.

Zevalin is not recommended during pregnancy due to potential risks; discuss family planning with your healthcare provider before treatment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibritumomab Tiuxetan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT